Patent: 9,675,648
Summary for Patent: 9,675,648
| Title: | Microbiota restoration therapy (MRT), compositions and methods of manufacture |
| Abstract: | Microbiota restoration therapy compositions and methods for manufacturing, processing, and/or delivering microbiota restoration therapy compositions are disclosed. An example method for manufacturing a microbiota restoration therapy composition may include collecting a human fecal sample and adding a diluent to the human fecal sample to form a diluted sample. The diluent may include a cryoprotectant. The method may also include mixing the diluted sample with a mixing apparatus and filtering the diluted sample. Filtering may form a filtrate. The method may also include transferring the filtrate to a sample bag and sealing the sample bag. |
| Inventor(s): | Lee A. Jones, Courtney R. Jones, Edwin J. Hlavka, Ryan D. Gordon |
| Assignee: | Ferring Microbiome Inc |
| Application Number: | US14/295,686 |
| Patent Claims: | see list of patent claims |
Details for Patent 9,675,648
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Ferring Pharmaceuticals Inc. | REBYOTA | fecal microbiota, live-jslm | Suspension | 125739 | November 30, 2022 | ⤷ Start Trial | 2034-06-04 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 9,675,648
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 2014275025 | ⤷ Start Trial |
| Australia | 2016202831 | ⤷ Start Trial |
| Australia | 2017201330 | ⤷ Start Trial |
| Australia | 2018220114 | ⤷ Start Trial |
| Australia | 2020202691 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
